Effect of BG-12 (dimethyl fumarate) in newly diagnosed patients with relapsing-remitting multiple sclerosis from the DEFINE and CONFIRM studies

被引：0
|
作者：
Gold, R.
Giovannoni, G.
Phillips, J. T.
Fox, R. J.
Zhang, A.
Meltzer, L.
Kurukulasuriya, N. C.
机构：
[1] Ruhr Univ Bochum, St Josef Hosp, Bochum, Germany
[2] Queen Mary Univ London, Blizard Inst, Barts & London Sch Med & Dent, London, England
[3] Baylor Inst Immunol Res, Multiple Sclerosis Program, Dallas, TX USA
[4] Cleveland Clin, Mellen Ctr Multiple Sclerosis Treatment & Res, Cleveland, OH 44106 USA
[5] Biogen Idec Inc, Weston, MA USA
来源：
JOURNAL OF NEUROLOGY | 2013年 / 260卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
O327
引用
收藏
页码：S51 / S51
页数：1
相关论文
共 50 条
  • [1] Effect of BG-12 (dimethyl fumarate) in newly diagnosed relapsing remitting multiple sclerosis (RRMS) patients from the DEFINE and CONFIRM studies
    Gold, R.
    Giovannoni, G.
    Phillips, J. T.
    Fox, R. J.
    Zhang, A.
    Meltzer, L.
    Kurukulasuriya, N. C.
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 453 - 454
  • [2] Oral BG-12 (dimethyl fumarate) for relapsing-remitting multiple sclerosis: a review of DEFINE and CONFIRM
    Havrdova, Eva
    Hutchinson, Michael
    Kurukulasuriya, Nuwan C.
    Raghupathi, Kartik
    Sweetser, Marianne T.
    Dawson, Katherine T.
    Gold, Ralf
    EXPERT OPINION ON PHARMACOTHERAPY, 2013, 14 (15) : 2145 - 2156
  • [3] Efficacy of Oral BG-12 (Dimethyl Fumarate) in Patients Newly Diagnosed with Relapsing-Remitting Multiple Sclerosis (RRMS): Integrated Analysis of DEFINE and CONFIRM
    Gold, R.
    Giovannoni, G.
    Phillips, J. T.
    Fox, R. J.
    Rana, J.
    Zhang, A.
    Meltzer, L.
    Kurukulasuriya, N. C.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 (07) : 931 - 932
  • [4] Effect of BG-12 (Dimethyl Fumarate) in Subgroups of Patients with Relapsing-Remitting Multiple Sclerosis: An Integrated Analysis of the Phase 3 DEFINE and CONFIRM Studies
    Bar-Or, Amit
    Fox, Robert
    Gold, Ralf
    Miller, David
    Arnold, Douglas
    O'Gorman, John
    Yang, Minhua
    Sheikh, Sarah
    Viglietta, Vissia
    Dawson, Katherine
    Hutchinson, Michael
    NEUROLOGY, 2013, 80
  • [5] Effect of BG-12 (Dimethyl Fumarate) in Subgroups of Patients with Relapsing-Remitting Multiple Sclerosis: Findings from Two Phase 3 Studies (DEFINE and CONFIRM)
    Hutchinson, M.
    Bar-Or, A.
    Fox, R. J.
    Gold, R.
    Giovannoni, G.
    Kita, M.
    O'Gorman, J.
    Yang, M.
    Sheikh, S. I.
    Viglietta, V.
    Dawson, K. T.
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (05) : 682 - 683
  • [6] An integrated analysis of the clinical efficacy of BG-12 (dimethyl fumarate) in patients with relapsing-remitting multiple sclerosis from the phase 3 DEFINE and CONFIRM studies
    Fox, R. J.
    Miller, D. H.
    Phillips, J. T.
    Arnold, D. L.
    Selmaj, K.
    Yang, M.
    Zhang, R.
    Dawson, K. T.
    Viglietta, V.
    Sheikh, S. I.
    Gold, R.
    JOURNAL OF NEUROLOGY, 2013, 260 : S74 - S74
  • [7] Gastrointestinal Tolerability Events in Relapsing-Remitting Multiple Sclerosis (RRMS) Patients Treated with Oral BG-12 (Dimethyl Fumarate) in DEFINE and CONFIRM
    Meltzer, Leslie
    Selmaj, Krzysztof
    Gold, Ralf
    Fox, Robert
    Havrdova, Eva
    Giovannoni, Gavin
    Pace, Amy
    Novas, Mark
    Hotermans, Christophe
    Dawson, Katherine
    Phillips, J. Theodore
    NEUROLOGY, 2013, 80
  • [8] Gastrointestinal Tolerability Events in Relapsing-Remitting Multiple Sclerosis (RRMS) Patients Treated with Oral Bg-12 (Dimethyl Fumarate) in Define and Confirm
    Bar-Or, A.
    Selmaj, K.
    Gold, R.
    Fox, R. J.
    Havrdova, E.
    Kurukulasuriya, N. C.
    Pace, A.
    Novas, M.
    Meltzer, L.
    Hotermans, C.
    Dawson, K. T.
    Phillips, J. T.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 (12) : 1840 - 1841
  • [9] An integrated analysis of the clinical and neuroradiological effect of BG-12 (dimethyl fumarate) in subgroups of patients with relapsing-remitting multiple sclerosis from the phase 3 DEFINE and CONFIRM studies
    Bar-Or, A.
    Fox, R. J.
    Gold, R.
    Miller, D. H.
    Arnold, D. L.
    O'Gorman, J.
    Yang, M.
    Sheikh, S. I.
    Viglietta, V.
    Dawson, K. T.
    Hutchinson, M.
    JOURNAL OF NEUROLOGY, 2013, 260 : S13 - S13
  • [10] Effect of BG-12 in subgroups of patients with relapsing-remitting multiple sclerosis: findings from the CONFIRM (Comparator and an Oral Fumarate in Relapsing-Remitting Multiple Sclerosis) study
    Hutchinson, M.
    Fox, R. J.
    Miller, D.
    Phillips, J. T.
    Kita, M.
    Havrdova, E.
    Yang, M.
    Zhang, R.
    Novas, M.
    Viglietta, V.
    Dawson, K. T.
    JOURNAL OF NEUROLOGY, 2012, 259 : S105 - S106
12345